Literature DB >> 9242331

Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer.

M T Lotze.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9242331      PMCID： PMC1190900          DOI： 10.1097/00000658-199707000-00001

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  40 in total

1.  Aberrant antigen presentation by macrophages from tumor-bearing mice is involved in the down-regulation of their T cell responses.

Authors:  G A Watson; D M Lopez
Journal:  J Immunol       Date:  1995-09-15       Impact factor: 5.422

Review 2.  Dendritic cells as initiators of tumor immune responses: a possible strategy for tumor immunotherapy?

Authors:  S Grabbe; S Beissert; T Schwarz; R D Granstein
Journal:  Immunol Today       Date:  1995-03

3.  Expression of relB is required for the development of thymic medulla and dendritic cells.

Authors:  L Burkly; C Hession; L Ogata; C Reilly; L A Marconi; D Olson; R Tizard; R Cate; D Lo
Journal:  Nature       Date:  1995-02-09       Impact factor: 49.962

4.  Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.

Authors:  L J Zhou; T F Tedder
Journal:  J Immunol       Date:  1995-04-15       Impact factor: 5.422

5.  A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes.

Authors:  O Devergne; M Hummel; H Koeppen; M M Le Beau; E C Nathanson; E Kieff; M Birkenbach
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

6.  Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells.

Authors:  F J Hsu; C Benike; F Fagnoni; T M Liles; D Czerwinski; B Taidi; E G Engleman; R Levy
Journal:  Nat Med       Date:  1996-01       Impact factor: 53.440

7.  Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity.

Authors:  J I Mayordomo; T Zorina; W J Storkus; L Zitvogel; C Celluzzi; L D Falo; C J Melief; S T Ildstad; W M Kast; A B Deleo
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

8.  Bone marrow-generated dendritic cells pulsed with a class I-restricted peptide are potent inducers of cytotoxic T lymphocytes.

Authors:  A Porgador; E Gilboa
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

9.  Proliferating dendritic cell progenitors in human blood.

Authors:  N Romani; S Gruner; D Brang; E Kämpgen; A Lenz; B Trockenbacher; G Konwalinka; P O Fritsch; R M Steinman; G Schuler
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

10.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307
View more
  14 in total

Review 1.  Tissue-resident dendritic cells and diseases involving dendritic cell malfunction.

Authors:  Keqiang Chen; Ji Ming Wang; Ruoxi Yuan; Xiang Yi; Liangzhu Li; Wanghua Gong; Tianshu Yang; Liwu Li; Shaobo Su
Journal:  Int Immunopharmacol       Date:  2016-02-22       Impact factor: 4.932

Review 2.  Pattern response of dendritic cells in the tumor microenvironment and breast cancer.

Authors:  Alessandra da Cunha; Marcia A Michelin; Eddie Fc Murta
Journal:  World J Clin Oncol       Date:  2014-08-10

3.  Mediastinal seminoma with florid follicular lymphoid hyperplasia: a clinicopathological and immunohistochemical study of six cases.

Authors:  Annikka Weissferdt; Cesar A Moran
Journal:  Virchows Arch       Date:  2014-11-26       Impact factor: 4.064

4.  Dendritic Cells-based Vaccine and Immune Monitoring for Hepatocellular Carcinoma.

Authors:  Dae-Heui Lee
Journal:  Korean J Physiol Pharmacol       Date:  2010-02-28       Impact factor: 2.016

5.  T helper 17 cells promote cytotoxic T cell activation in tumor immunity.

Authors:  Natalia Martin-Orozco; Pawel Muranski; Yeonseok Chung; Xuexian O Yang; Tomohide Yamazaki; Sijie Lu; Patrick Hwu; Nicholas P Restifo; Willem W Overwijk; Chen Dong
Journal:  Immunity       Date:  2009-10-29       Impact factor: 31.745

6.  Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins.

Authors:  G Pirtskhalaishvili; G V Shurin; C Esche; Q Cai; R R Salup; S N Bykovskaia; M T Lotze; M R Shurin
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

Review 7.  The Emerging Role of CD244 Signaling in Immune Cells of the Tumor Microenvironment.

Authors:  Laura Agresta; Kasper H N Hoebe; Edith M Janssen
Journal:  Front Immunol       Date:  2018-11-28       Impact factor: 7.561

8.  Dendritic cells in the cancer microenvironment.

Authors:  Yang Ma; Galina V Shurin; Zhu Peiyuan; Michael R Shurin
Journal:  J Cancer       Date:  2012-12-15       Impact factor: 4.207

9.  Morphologic evidence of anti-tumor specificity of T cells activated by denritic cells derived from peripheral blood mononuclear cells of thyroid cancer patients.

Authors:  Dae-Heui Lee
Journal:  Korean J Physiol Pharmacol       Date:  2012-08-10       Impact factor: 2.016

10.  Human breast cancer-derived soluble factors facilitate CCL19-induced chemotaxis of human dendritic cells.

Authors:  Hyundoo Hwang; Changsik Shin; Juhee Park; Enoch Kang; Bongseo Choi; Jae-A Han; Yoonkyung Do; Seongho Ryu; Yoon-Kyoung Cho
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.